{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T02:28:47Z","timestamp":1791340127916,"version":"4.3.1"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2010,8,19]],"date-time":"2010-08-19T00:00:00Z","timestamp":1282176000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2010,8,19]],"date-time":"2010-08-19T00:00:00Z","timestamp":1282176000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Leukemia"],"published-print":{"date-parts":[[2010,10]]},"DOI":"10.1038\/leu.2010.163","type":"journal-article","created":{"date-parts":[[2010,8,19]],"date-time":"2010-08-19T12:50:01Z","timestamp":1282222201000},"page":"1713-1718","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":167,"title":["LNK mutation studies in blast-phase myeloproliferative neoplasms, and in chronic-phase disease with TET2, IDH, JAK2 or MPL mutations"],"prefix":"10.1038","volume":"24","author":[{"given":"A","family":"Pardanani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T","family":"Lasho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Finke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S T","family":"Oh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Gotlib","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Tefferi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,8,19]]},"reference":[{"key":"BFleu2010163_CR1","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1038\/sj.leu.2404948","volume":"22","author":"A Pardanani","year":"2008","unstructured":"Pardanani A . JAK2 inhibitor therapy in myeloproliferative disorders: rationale, preclinical studies and ongoing clinical trials. Leukemia 2008; 22: 23\u201330.","journal-title":"Leukemia"},{"key":"BFleu2010163_CR2","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1038\/leu.2008.113","volume":"22","author":"AM Vannucchi","year":"2008","unstructured":"Vannucchi AM, Antonioli E, Guglielmelli P, Pardanani A, Tefferi A . Clinical correlates of JAK2V617F presence or allele burden in myeloproliferative neoplasms: a critical reappraisal. Leukemia 2008; 22: 1299\u20131307.","journal-title":"Leukemia"},{"key":"BFleu2010163_CR3","doi-asserted-by":"publisher","first-page":"1960","DOI":"10.1038\/sj.leu.2404810","volume":"21","author":"A Pardanani","year":"2007","unstructured":"Pardanani A, Lasho TL, Finke C, Hanson CA, Tefferi A . Prevalence and clinicopathologic correlates of JAK2 exon 12 mutations in JAK2V617F-negative polycythemia vera. Leukemia 2007; 21: 1960\u20131963.","journal-title":"Leukemia"},{"key":"BFleu2010163_CR4","doi-asserted-by":"publisher","first-page":"3472","DOI":"10.1182\/blood-2006-04-018879","volume":"108","author":"AD Pardanani","year":"2006","unstructured":"Pardanani AD, Levine RL, Lasho T, Pikman Y, Mesa RA, Wadleigh M et al. MPL515 mutations in myeloproliferative and other myeloid disorders: a study of 1182 patients. Blood 2006; 108: 3472\u20133476.","journal-title":"Blood"},{"key":"BFleu2010163_CR5","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1084\/jem.20040762","volume":"200","author":"W Tong","year":"2004","unstructured":"Tong W, Lodish HF . Lnk inhibits Tpo-mpl signaling and Tpo-mediated megakaryocytopoiesis. J Exp Med 2004; 200: 569\u2013580.","journal-title":"J Exp Med"},{"key":"BFleu2010163_CR6","doi-asserted-by":"publisher","first-page":"4604","DOI":"10.1182\/blood-2004-10-4093","volume":"105","author":"W Tong","year":"2005","unstructured":"Tong W, Zhang J, Lodish HF . Lnk inhibits erythropoiesis and Epo-dependent JAK2 activation and downstream signaling pathways. Blood 2005; 105: 4604\u20134612.","journal-title":"Blood"},{"key":"BFleu2010163_CR7","first-page":"2832","volume":"118","author":"A Bersenev","year":"2008","unstructured":"Bersenev A, Wu C, Balcerek J, Tong W . Lnk controls mouse hematopoietic stem cell self-renewal and quiescence through direct interactions with JAK2. J Clin Invest 2008; 118: 2832\u20132844.","journal-title":"J Clin Invest"},{"key":"BFleu2010163_CR8","doi-asserted-by":"publisher","first-page":"3360","DOI":"10.1182\/blood-2007-05-089326","volume":"110","author":"S Gery","year":"2007","unstructured":"Gery S, Gueller S, Chumakova K, Kawamata N, Liu L, Koeffler HP . Adaptor protein Lnk negatively regulates the mutant MPL, MPLW515L associated with myeloproliferative disorders. Blood 2007; 110: 3360\u20133364.","journal-title":"Blood"},{"key":"BFleu2010163_CR9","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1189\/jlb.0908575","volume":"85","author":"S Gery","year":"2009","unstructured":"Gery S, Cao Q, Gueller S, Xing H, Tefferi A, Koeffler HP . Lnk inhibits myeloproliferative disorder-associated JAK2 mutant, JAK2V617F. J Leukoc Biol 2009; 85: 957\u2013965.","journal-title":"J Leukoc Biol"},{"key":"BFleu2010163_CR10","doi-asserted-by":"publisher","first-page":"2058","DOI":"10.1172\/JCI42032","volume":"120","author":"A Bersenev","year":"2010","unstructured":"Bersenev A, Wu C, Balcerek J, Jing J, Kundu M, Blobel GA et al. Lnk constrains myeloproliferative diseases in mice. J Clin Invest 2010; 120: 2058\u20132069.","journal-title":"J Clin Invest"},{"key":"BFleu2010163_CR11","doi-asserted-by":"crossref","unstructured":"Oh ST, Simonds EF, Jones C, Hale MB, Goltsev Y, Gibbs Jr KD et al. Novel mutations in the inhibitory adaptor protein LNK drive JAK-STAT signaling in patients with myeloproliferative neoplasms. Blood First edition paper, prepublished online 19 April 2010; DOI 10.1182\/blood-2010-02-270108.","DOI":"10.1182\/blood-2010-02-270108"},{"key":"BFleu2010163_CR12","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1182\/blood-2009-03-209262","volume":"114","author":"JW Vardiman","year":"2009","unstructured":"Vardiman JW, Thiele J, Arber DA, Brunning RD, Borowitz MJ, Porwit A et al. The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes. Blood 2009; 114: 937\u2013951.","journal-title":"Blood"},{"key":"BFleu2010163_CR13","doi-asserted-by":"publisher","first-page":"2074","DOI":"10.1038\/sj.leu.2404724","volume":"21","author":"A Tefferi","year":"2007","unstructured":"Tefferi A, Strand JJ, Lasho TL, Knudson RA, Finke CM, Gangat N et al. Bone marrow JAK2V617F allele burden and clinical correlates in polycythemia vera. Leukemia 2007; 21: 2074\u20132075.","journal-title":"Leukemia"},{"key":"BFleu2010163_CR14","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.1038\/leu.2010.77","volume":"24","author":"A Pardanani","year":"2010","unstructured":"Pardanani A, Lasho TL, Finke CM, Mai M, McClure RF, Tefferi A . IDH1 and IDH2 mutation analysis in chronic- and blast-phase myeloproliferative neoplasms. Leukemia 2010; 24: 1146\u20131151.","journal-title":"Leukemia"},{"key":"BFleu2010163_CR15","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1038\/leu.2009.47","volume":"23","author":"A Tefferi","year":"2009","unstructured":"Tefferi A, Pardanani A, Lim KH, Abdel-Wahab O, Lasho TL, Patel J et al. TET2 mutations and their clinical correlates in polycythemia vera, essential thrombocythemia and myelofibrosis. Leukemia 2009; 23: 905\u2013911.","journal-title":"Leukemia"},{"key":"BFleu2010163_CR16","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1182\/blood-2006-12-062125","volume":"110","author":"A Theocharides","year":"2007","unstructured":"Theocharides A, Boissinot M, Girodon F, Garand R, Teo SS, Lippert E et al. Leukemic blasts in transformed JAK2-V617F-positive myeloproliferative disorders are frequently negative for the JAK2-V617F mutation. Blood 2007; 110: 375\u2013379.","journal-title":"Blood"},{"key":"BFleu2010163_CR17","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1158\/0008-5472.CAN-09-3783","volume":"70","author":"O Abdel-Wahab","year":"2010","unstructured":"Abdel-Wahab O, Manshouri T, Patel J, Harris K, Yao J, Hedvat C et al. Genetic analysis of transforming events that convert chronic myeloproliferative neoplasms to leukemias. Cancer Res 2010; 70: 447\u2013452.","journal-title":"Cancer Res"}],"container-title":["Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/leu2010163.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/leu2010163","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/leu2010163.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T13:37:01Z","timestamp":1648733821000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/leu2010163"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,8,19]]},"references-count":17,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2010,10]]}},"alternative-id":["BFleu2010163"],"URL":"https:\/\/doi.org\/10.1038\/leu.2010.163","relation":{},"ISSN":["0887-6924","1476-5551"],"issn-type":[{"value":"0887-6924","type":"print"},{"value":"1476-5551","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,8,19]]},"assertion":[{"value":"23 May 2010","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 June 2010","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 August 2010","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}